GLP-1 Tablets vs Injections: Which Is Right for You?

Eligible patients in the UK can access GLP-1 medications for weight management. They have always been in injectable form, but today, you can get weight loss pills through private clinics and pharmacies.

GLP-1 pills have opened up the weight loss market to people who may be uncomfortable with needles but still need treatment. However, the question many people are asking is: Is there a difference between these types of medications?

Both formats are effective for weight loss, but they differ in dosing schedules, administration, doses, and how much weight you can lose.

This guide compares the two forms and explains how Curely can help you choose the best weight-loss medication for your needs.

Key Takeaways

• GLP-1 tablets and injections can support weight loss and have similar eligibility requirements but differ in administration and dosing schedules.
• You take GLP-1 tablets daily and injections once a week.
• Tablets may be suitable for people who are uncomfortable with needles, while injections may be better for patients who struggle to keep up with daily dosing.
• The right option depends on your health, lifestyle, treatment preferences, and ability to stick to the dosing schedule.
• Always speak with a healthcare professional before switching or choosing between GLP-1 treatments.

What Are GLP-1 Medicines?

GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after you eat. It slows how quickly food leaves the stomach and signals fullness to the brain. The hormone can also prompt insulin release when blood glucose rises.

GLP-1 medicines imitate that hormone, reducing your appetite and making you feel full. Clinical trials show you can lose weight because you eat fewer calories while taking the medications. These treatments can also reduce constant thoughts about eating (food noise), making it easier to avoid snacking and overeating.

Types of GLP-1 Medications in the UK: Tablets and Injections

Supports lasting weight management

Mounjaro

Safe and Secure Medication

View Mounjaro Options

GLP-1 medicines are available to eligible patients in the UK as prescription weight loss treatments in two forms:

1. Injectables

GLP-1 weight loss injections come as a once-weekly pre-filled pen, administered subcutaneously (e.g., abdomen, thigh, upper arm). You must have a prescription to access these weight loss medications and meet eligibility criteria such as:

• 18 years or older
• Body Mass Index (BMI) of 30 or higher
• BMI of 27 or higher with at least one weight-related health condition (such as high blood pressure, pre diabetes, high cholesterol, or sleep apnoea)

There are two main GLP-1 injections licensed for weight management in the UK:

• Mounjaro: It's a dual GIP & GLP-1 receptor agonist that contains the active ingredient Tirzepatide. SURMOUNT-1 clinical evidence shows an average weight loss of 20% to 22.5% on the highest dose. Mounjaro is available in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg.
• Wegovy Injection: This GLP-1 receptor agonist contains semaglutide. According to the STEP 1 and STEP UP clinical trials, it can trigger weight loss of 15% to 20.7%. Wegovy injection comes in 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg, and 7.2 mg.

Our guide to which GLP-1 is best for weight loss compares Wegovy and Mounjaro to help you choose the best one for your needs.

Benefits of Weight Loss Injections

• Convenient Schedule: People who struggle to remember a daily pill may find a weekly injection more convenient.
• Larger Evidence Base: The major cardiovascular outcome trials (e.g., SELECT) and primary Phase 3 weight loss trials (STEP and SURMOUNT programs) were pioneered using weekly subcutaneous injections, giving them years of real-world post-marketing safety data.
• Dual-Pathway Options: Tirzepatide acts on both GIP and GLP-1, and is currently available as an injection.

2. Tablet Options

Daily tablet for appetite control

Wegovy Pill

Weight loss support without injections

View Wegovy Options

An oral semaglutide tablet (Rybelsus) was already available in the UK, but it was strictly licensed for Type 2 diabetes. The availability of oral GLP-1 formulations licensed and dosed specifically for weight management is recent.

Like injections, weight-loss pills require a prescription. They're also only available to people who meet the same eligibility requirements as weight-loss injections.

The following GLP-1 oral weight loss medications are available in the UK:

• Wegovy Pill: This contains the same active ingredient as the injection, semaglutide. You take it once daily on an empty stomach, followed by a 30-minute fast. It works the same way as the injection. The Wegovy pill is available in 1.5 mg, 4 mg, 9 mg, and 25 mg. The OASIS 4 clinical trials show the pill can trigger weight loss of about 13.6% to 16.6% of body weight over 64 weeks on the highest dose.
• Foundayo (Orforglipron): This is a daily non-peptide small-molecule GLP-1 tablet manufactured by Eli Lilly. You can take it at any time of day with no food or water restrictions. Foundayo is available in 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, and 17.2 mg. The ATTAIN-1 clinical trials show you can lose up to 11.1% of body weight over 72 weeks on the maximum dose.

Benefits of Oral GLP-1 UK Medications

• No Needles: Tablets are good for people who are anxious or uncomfortable with needles but still need weight loss treatment.
• No Disposables: Pill options mean you won't need a biohazard sharps bin or needle disposal routines.
• Easier Travel: You can travel with GLP-1 medications in your bag because they don't need special storage or carrying medical letters for needles through airport security.

GLP-1 Pills vs Injections at a Glance

Key Differences Between Oral and Injectable GLP-1 Treatments

1. Dosing Schedule & Frequency

Tablets require once-daily dosing (365 doses a year) to maintain effective drug levels in your body. Injections need once-weekly administration (52 doses a year) because of their longer-acting molecular design.

2. Food, Water, and Fasting Requirements

The Wegovy pill is highly sensitive to stomach acid and food, so you must swallow it first thing in the morning on an empty stomach with a small sip of water, then wait 30 minutes before eating, drinking, or taking other medications.

Foundayo is a chemically stable non-peptide that you can take at any time of day, with or without food or water restrictions.

Digestion doesn't affect GLP-1 injections, so you can administer them at any time of the day, with or without meals.

3. Receptor Pathways

The currently available tablets are single GLP-1 receptor agonists, while injections include single GLP-1 agonists (Wegovy) and dual GIP/GLP-1 receptor agonists (Mounjaro).

4. Average Weight Loss Efficacy

Tablets show strong weight-loss outcomes, averaging ~11% to 16.6% total body weight reduction in clinical trials, depending on the drug and dose. Injections have slightly higher clinical trial results, averaging ~15% to 22.5% total body weight loss. However, note that this is not a direct comparison with weight-loss pills.

Similarities Between GLP-1 Injections and Tablets

Daily Oral GLP-1 Treatment

Foundayo

Helps reduce appetite and hunger.

View Foundayo Options

• Core Mechanism & Efficacy: Both use an active medicine that mimics your body's natural hormones. This helps you feel full faster, reduces cravings, regulates blood sugar, and leads to significant weight loss for many patients.
• Lifestyle Integration: Both medications require pairing with a healthy, reduced-calorie diet and regular exercise for the best results.
• Titration & Dosing Schedule: Treatment for both starts at lower initial doses, followed by gradual increases and adjustments based on response and weight-loss goals.
• Prescription Criteria & Screening: Both types of medications are prescription-only. UK patients can access them only after meeting specific clinical eligibility criteria (such as BMI thresholds) and passing safety screenings, including a review of personal or family history for specific endocrine conditions.
• Broader Health Benefits: Beyond weight management, both formats may improve metabolic markers (blood sugar, cholesterol, blood pressure, and waist circumference). Some medications can also offer protective benefits for patients at high cardiovascular risk or with established cardiovascular disease.
• Side Effects: These medications usually have the same side effects, such as abdominal discomfort, nausea, vomiting, and diarrhoea. These symptoms may worsen during dose increases or when starting treatment.
• Monitoring & Nutrition: Both options require regular medical supervision to monitor progress, adjust dosages, help manage side effects, and prevent nutritional deficiencies from eating less.

Weight Loss Tablets vs Injections: How to Choose the Right One

Choosing between oral and injectable GLP-1 forms for weight loss depends on your lifestyle and personal preferences. Most patients consider the following when selecting between the two:

1. Administration & Daily Routine

The most obvious difference between oral tablets and injections is how you take them. Semaglutide pills require a specific daily routine, while Foundayo offers more flexibility without strict food or fasting rules. Some people also prefer pills because they may be uncomfortable with injections. On the other hand, you take injectable forms once weekly, which some people find easier to manage than a daily pill.

2. Efficacy

Both formats have effective outcomes, though trial results vary significantly depending on the specific drug and dosage. However, clinical trials show that injections usually produce greater weight loss than oral forms. Note that this is not a direct comparison, but individual studies.

3. Skin Irritation

Because both formats work through the same GLP-1 pathways, their common side effects are similar, usually mild-to-moderate GI symptoms such as nausea, mild cramping, constipation, and diarrhoea. However, using pens may occasionally cause mild redness, itching, or bruising at the injection site.

Can You Switch Between GLP-1 Tablets and Injections?

Convenient once-weekly dosing

Wegovy injection

Supports appetite control and weight loss

View Wegovy Options

You can switch from pills to injections and vice versa due to:

• Adherence: A person who keeps forgetting their daily pill can switch to a once-weekly shot to fit their lifestyle better. Similarly, someone who's terrified or uncomfortable with needles might switch to daily tablets.
• Tolerance & Side Effects: Switching formats can help if you experience injection site reactions or localized stomach upset from tablets.
• Availability: Stock levels or supply chain changes can make one format easier to access than the other.

Note, however, that you can't switch from one medication to another by yourself because the milligram doses aren't equal. It could cause severe side effects, so always speak with your healthcare professional before switching.

Getting GLP-1 Treatment with Curely

Curely is a UK-registered online clinic and pharmacy that offers GLP-1 treatments for weight loss. UK patients can safely access injections and pills through our clinic after a thorough assessment.

Complete a short online consultation covering your medical history, BMI, current medications, and weight loss goals. Our clinical team will review your answers and recommend the right treatments for you.

After approval, we'll send the medication to your address in discreet packaging. Our team provides ongoing support during treatment, so you can reach out with questions about side effects and dose adjustments.

Start your consultation with Curely today.

FAQs

Can You Get GLP-1 Tablets on the NHS?

You can get oral semaglutide through the NHS (National Health Service), but strictly for type 2 diabetes, not weight loss. Most people in the UK access oral GLP-1 treatments for weight management through private channels such as Curely.

Which Is Cheaper, GLP-1 Tablets or Injections?

Pricing varies by treatment, dose, provider, and manufacturing costs over time. Both start at a lower price for the starter doses, then increase as you move up. Price shouldn't be the primary consideration for selecting a treatment. Always compare additional features such as the level of ongoing support from your prescriber.

Is It Easier to Stop Taking GLP-1 Tablets Than Injections?

Because GLP-1 pills build up steady levels in your blood, the medicine takes several weeks to fully leave your body, just like the weekly injection. Never stop taking either medication on your own. Speak with the prescriber so they can help you gradually lower your dose and create a plan to manage returning hunger so you can maintain weight loss results.

Final Thoughts

GLP-1 medications in the UK are available in pill and injection formats. They share similarities, such as effectiveness and eligibility requirements, but one may suit you better depending on your preferences and how you respond to the medication.

Pills may be better for patients who are uncomfortable with needles, while injections may be more suited to people who may struggle with remembering to take a daily pill. However, the final decision should depend on your health and the prescriber's recommendation.

Curely can help you choose the right medication for your weight loss goals and lifestyle. Reach out today for regulated GLP-1 weight loss treatments.

Reference List

• Eli Lilly. Lilly’s Tirzepatide Delivered up to 22.5% Weight Loss in Adults with Obesity or Overweight in SURMOUNT-1 | Eli Lilly and Company. 2022.
• Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387(3):205-216.
• Knop FK, Aroda VR, Ruben, et al. Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. 2023;402(10403).
• Lilly E. Lilly’s oral GLP-1, orforglipron, demonstrated meaningful weight loss and cardiometabolic improvements in complete ATTAIN-1 results published in The New England Journal of Medicine | Eli Lilly and Company. Eli Lilly and Company. 2024.
• Roberts M. Weight-loss drug Wegovy to be available in pill form in UK for first time. BBC. June 11, 2026.
• Wharton S, Aronne LJ, Stefanski A, et al. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment. New England Journal of Medicine. 2025;393(18):1796-1806.
• Wharton S, Freitas P, Jøran Hjelmesæth, et al. Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial. The Lancet Diabetes & Endocrinology. Published online September 1, 2025.
• Wharton S, Ildiko Lingvay, Bogdanski P, et al. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. New England Journal of Medicine. 2025;393(11):1077-1087.